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Introduction: 
The objective of this joint U.S. - Russian project was the development and validation of an in-
flight methodology to assess a number of cardiac and vascular parameters associated with 
circulating volume and its manipulation in long-duration space flight. Responses to modified 
Valsalva and Mueller maneuvers were measured by cardiac and vascular ultrasound (US) before, 
during, and after temporary volume reduction by means of Braslet-M thigh occlusion cuffs 
(Russia).  
Materials and Methods: 
 The study protocol was conducted in 14 sessions on 9 ISS crewmembers, with an average 
exposure to microgravity of 122 days. Baseline cardiovascular measurements were taken by 
echocardiography in multiple modes (including tissue Doppler of both ventricles) and femoral 
and jugular vein imaging on the International Space Station (ISS). The Braslet devices were then 
applied and measurements were repeated after >10 minutes. The cuffs were then released and the 
hemodynamic recovery process was monitored.  Modified Valsalva and Mueller maneuvers were 
used throughout the protocol. All US data were acquired by the HDI-5000 ultrasound system 
aboard the ISS (ATL/Philips, USA) during remotely guided sessions. The study protocol, 
including the use of Braslet-M for this purpose, was approved by the ISS Human Research 
Multilateral Review Board (HRMRB).  
Results:  
The effects of fluid sequestration on a number of echocardiographic and vascular parameters 
were readily detectable by in-flight US, as were responses to respiratory maneuvers. The overall 
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volume status assessment methodology appears to be valid and practical, with a decrease in left 
heart lateral E‘ (tissue Doppler) as one of the most reliable measures. Increase in the femoral 
vein cross-sectional areas was consistently observed with Braslet application. Other significant 
differences and trends within the extensive cardiovascular data were also observed. (Decreased - 
RV and LV preload indices, Cardiac Output, LV E’ all maneuvers, LV Stroke Volume). 
 
Conclusions:  
This Study: 
1) Addressed specific aspects of operational space medicine and space physiology, including 
assessment of circulating volume disturbances 
2) Expanded the applications of diagnostic ultrasound imaging and Doppler techniques in 
microgravity.  
3) Used respiratory maneuvers against the background of acute circulating volume 
manipulations which appear to enhance our ability to noninvasively detect volume-
dependency in a number of cardiac and vascular parameters. 
4) Determined that Tei index is not clinically changed therefore contractility not altered in the 
face of reduced preload. 
5) Determined that increased Femoral Vein Area indicating blood being sequestered in lower 
extremities correlates with reduced preload and cardiac output. 
6) That Braslet may be the only feasible means of acutely treating high pressure pulmonary 
edema in reduced gravity environments. 
 
